Nachrichten zur Abbvie Inc. Aktie

North ChicagoWien (www.aktiencheck.de) - AbbVie-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), rät in…

Revolution Medicines stock surges over 20% on potential AbbVie acquisition…

AbbVie is in advanced talks to buy cancer-drug developer Revolution Medicines , the Wall Street Journal reported on Wednesday, citing…

AbbVie in talks to buy biotech Revolution Medicines, WSJ reports…

The latest trading day saw AbbVie (ABBV) settling at $220.18, representing a -3.98% change from its previous close.…

…

…

ABBV, KO and CVX headline Zacks top stock reports as analysts flag growth drivers, strategic moves and key headwinds shaping…

AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply…

AbbVies third-quarter earnings were disappointing, but the company raised its full-year guidance and increased the dividend.…

AbbVie, several other pharma companies near MFN deal with Trump, sources say…

The latest trading day saw AbbVie (ABBV) settling at $227.45, representing a +1.85% change from its previous close.…

AbbVie dips below its 50-day SMA, but strong immunology momentum and a resilient long-term trend keep the story compelling.…

AbbVie (ABBV) concluded the recent trading session at $223.12, signifying a -1.31% move from its prior days close.…

AbbVie Inc. (NYSE:ABBV) engages in the research and development, manufacture, and sale of medicines and therapies worldwide. It is set…

AbbVie Inc.s ( NYSE:ABBV ) dividend will be increasing from last years payment of the same period to $1.73 on…

Image source: The Motley Fool.DateThursday, November 6, 2025 at 4:16 p.m. ETCall participantsPresident and CEO — Curran SimpsonChief Medical Officer…

ABBVs surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.…

ABBVs neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD treatments fueling growth.…

Its no reason to stay up at night.…

Key PointsSCHD charges a slightly lower expense ratio and offers a higher dividend yield than HDVHDV has delivered better 1-year…

…

Heute vor 5 Jahren wurden AbbVie-Anteile an der Börse NYSE gehandelt. Zur Schlussglocke war das Papier an diesem Tag…

ABBV tops Q3 earnings and revenue estimates, driven by Rinvoq and Skyrizi gains, and lifts its 2025 EPS outlook.…

Frankfurt (www.aktiencheck.de) - AbbVie-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie von AbbVie Inc. (ISIN: US00287Y1091, WKN: A1J84E, Ticker-Symbol:…

While the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed in the quarter…

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

Image source: The Motley Fool.DATEFriday, Oct. 31, 2025 at 9 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Robert A.…

AbbVie raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq helped boost…

Key PointsSCHD and FDVV diverge on sector tilts, yield, and fees.Schwab U.S. Dividend Equity ETF (SCHD) offers a higher payout…

Key PointsRailway Pension increased its Mastercard stake by 240,000 shares; an estimated $137.83 million trade based on the quarterly average…

Key PointsSouth Carolina-based Apricus Wealth added 42,386 shares of ONEOK for an estimated $3.3 million during the third quarter.The transaction…

Key PointsSouth Carolina-based Apricus Wealth sold 10,784 shares of JPMorgan Chase & Co. for an estimated $3.2 million in the…

Key PointsLetson Investment Management acquired 73,166 shares of Fiserv with an estimated trade size of $9.43 million as of September…